Massimo Massaia

7.6k total citations
157 papers, 4.4k citations indexed

About

Massimo Massaia is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Massimo Massaia has authored 157 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Immunology, 70 papers in Hematology and 40 papers in Oncology. Recurrent topics in Massimo Massaia's work include Multiple Myeloma Research and Treatments (62 papers), Immune Cell Function and Interaction (35 papers) and T-cell and B-cell Immunology (35 papers). Massimo Massaia is often cited by papers focused on Multiple Myeloma Research and Treatments (62 papers), Immune Cell Function and Interaction (35 papers) and T-cell and B-cell Immunology (35 papers). Massimo Massaia collaborates with scholars based in Italy, United States and France. Massimo Massaia's co-authors include Mario Boccadoro, Alessandro Pileri, Chiara Riganti, Marta Coscia, Barbara Castella, Myriam Foglietta, Alberto Bianchi, Umberto Dianzani, Silvia Peola and C Attisano and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Massimo Massaia

151 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Massaia Italy	38	2.2k	1.6k	1.4k	1.4k	652	157	4.4k
Paul Browne Ireland	26	1.5k 0.7×	1.3k 0.8×	457 0.3×	858 0.6×	956 1.5×	68	3.7k
Ansgar Schulz Germany	33	1.7k 0.8×	1.1k 0.7×	986 0.7×	1.7k 1.2×	300 0.5×	122	4.5k
D. W. van Bekkum Netherlands	32	1.1k 0.5×	1.6k 1.0×	618 0.4×	864 0.6×	632 1.0×	136	3.7k
Hermine Agis Austria	32	1.9k 0.9×	875 0.6×	403 0.3×	824 0.6×	567 0.9×	123	3.2k
Andrew M. Yeager United States	30	689 0.3×	2.8k 1.8×	899 0.6×	996 0.7×	805 1.2×	91	4.5k
Shimon Slavin Israel	32	1.5k 0.7×	2.2k 1.4×	906 0.6×	542 0.4×	479 0.7×	166	4.3k
Ugo Ramenghi Italy	39	993 0.5×	1.4k 0.9×	648 0.5×	2.0k 1.4×	587 0.9×	153	4.4k
Peter Hokland Denmark	39	1.1k 0.5×	3.2k 2.1×	924 0.6×	2.5k 1.8×	1.2k 1.8×	232	6.1k
Toshiro Nagasawa Japan	35	743 0.3×	1.5k 1.0×	603 0.4×	1.2k 0.8×	581 0.9×	162	4.1k
Josè Antonio Pérez-Simón Spain	42	1.5k 0.7×	3.9k 2.5×	1.6k 1.1×	1.8k 1.3×	1.6k 2.5×	236	6.5k

Countries citing papers authored by Massimo Massaia

Since Specialization

Citations

This map shows the geographic impact of Massimo Massaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Massaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Massaia more than expected).

Fields of papers citing papers by Massimo Massaia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Massaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Massaia. The network helps show where Massimo Massaia may publish in the future.

Co-authorship network of co-authors of Massimo Massaia

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Massaia. A scholar is included among the top collaborators of Massimo Massaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Massaia. Massimo Massaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menardi, G, et al.. (2025). Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report. Journal of Medical Case Reports. 19(1). 27–27.

Maione, Federica, Daniele Oddo, Chiara Falcomatà, et al.. (2024). Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models. Molecular Oncology. 18(6). 1552–1570. 4 indexed citations

Massaia, Massimo, et al.. (2023). Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review. Journal of Clinical Medicine. 12(14). 4590–4590. 1 indexed citations

Giannotta, Claudia, et al.. (2023). The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells. Frontiers in Immunology. 13. 1102471–1102471. 20 indexed citations

Morandi, Fabio, Danilo Marimpietri, Alberto L. Horenstein, et al.. (2018). Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD⁺. OncoImmunology. 7(8). e1458809–e1458809. 68 indexed citations

Foglietta, Myriam, Barbara Castella, Sara Mariani, et al.. (2014). The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. Haematologica. 99(10). 1605–1610. 27 indexed citations

Chillemi, Antonella, Gianluca Zaccarello, Valeria Quarona, et al.. (2013). Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule. Molecular Medicine. 19(1). 99–108. 54 indexed citations

Bianco, Alessandra, et al.. (2011). Esperienza di collaborazione interdisciplinare farmacista di reparto-ematologo per la gestione della terapia antifungina sistemica in un reparto di ematologia. 57(5). 242–243. 1 indexed citations

Squadrone, Vincenzo, Massimo Massaia, Benedetto Bruno, et al.. (2010). Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Medicine. 36(10). 1666–1674. 95 indexed citations

10.

Coscia, Marta, Elena Quaglino, Manuela Iezzi, et al.. (2009). Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. Journal of Cellular and Molecular Medicine. 14(12). 2803–2815. 220 indexed citations

11.

Bruno, Benedetto, Roberto Sorasio, Patrizia Barozzi, et al.. (2006). Kaposi's sarcoma triggered by endogenous HHV‐8 reactivation after non‐myeloablative allogeneic haematopoietic transplantation. European Journal Of Haematology. 76(4). 342–347. 20 indexed citations

12.

Barosi, Giovanni, Mario Boccadoro, Michèle Cavo, et al.. (2004). Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).. PubMed. 89(6). 717–41. 57 indexed citations

13.

Bringhen, Sara, Alessandra Bertola, Federica Cavallo, et al.. (2003). TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS. Haematologica. 88. 17–18. 12 indexed citations

14.

Mariani, Sara, Marta Coscia, Jos Even, et al.. (2001). Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion. British Journal of Haematology. 113(4). 1051–1059. 42 indexed citations

15.

Bianchi, Alberto & Massimo Massaia. (1997). Idiotypic vaccination in B-cell malignancies. Molecular Medicine Today. 3(10). 435–441. 11 indexed citations

16.

Ponzetto, M, et al.. (1996). Hemorheolocical and photoplethysmographical modifications with aging. Archives of Gerontology and Geriatrics. 22. 207–211. 2 indexed citations

17.

Borrione, Paolo, et al.. (1996). Clinical and Immunological Studies in Advanced Cancer Patients Sequentially Treated with Anti CD3 Monoclonal Antibody (OKT3) and Interleukin-2. Leukemia & lymphoma. 21(3-4). 325–330. 7 indexed citations

18.

Peola, Silvia, Paolo Borrione, Lina Matera, et al.. (1996). Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities. The Journal of Immunology. 157(10). 4354–4362. 30 indexed citations

19.

Bianchi, Alberto, Nadia Carlesso, Silvia Peola, et al.. (1994). Generation of anti‐tumour activity by OKT3‐stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis. British Journal of Haematology. 87(3). 494–502. 6 indexed citations

20.

Boccadoro, Mario, Filippo Marmont, M Tribalto, et al.. (1989). Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis.. Journal of Clinical Oncology. 7(1). 119–125. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact